Skip to content

Supplier News

Bell launches promo campaign for Jet-Alert

Bell launches promo campaign for Jet-Alert

Bell Pharmaceuticals has kicked off an eight-month promotional campaign for its Jet-Alert caffeine tablets on Sirius XM radio. The company said Thursday that the marketing push also includes online advertisements, national print advertising, social media campaigns and retailer support programs.

FDA works to speed generic drug approvals

FDA works to speed generic drug approvals

Amid calls for a quicker approval process, the Food and Drug Administration last year cleared for market the most generic drug products in its history. The FDA said it approved or issued tentative approvals for more than 700 generic drugs in 2015.

Novartis realigns pharma division into two new units

Novartis realigns pharma division into two new units

Making changes to its Pharmaceuticals Division, Novartis has created two business units that will report to the chief executive officer: Novartis Pharmaceuticals and Novartis Oncology. The new units will form the Innovative Medicines Division.

Premier Brands unveils Arm & Hammer foot care line

Premier Brands unveils Arm & Hammer foot care line

Premier Brands of America has introduced a line of foot care products under the Arm & Hammer brand. Premier Brands said late Monday that the spring 2016 lineup of insoles, sprays and powders will offer superior performance in terms of comfort and odor mitigation.

Axxess Pharma expands OTC lineup

Axxess Pharma expands OTC lineup

Axxess Pharma Inc. is targeting large pharmacy retailers with a pair of new over-the-counter health products. Known for nutritional supplement, pain relief and other products under the TapouT brand, Axxess said that through its AllStar Health Brands Inc.

Aurobindo cleared to market Opana generic

Aurobindo cleared to market Opana generic

Aurobindo Pharma Ltd. has gained approval from the Food and Drug Administration for oxymorphone HCl tablets 5 mg and 10 mg, an opioid painkiller. Aurobindo said Thursday that its oxymorphone tablet product is a generic version of Opana tablets (5 mg and 10 mg) from Endo Pharmaceuticals Inc.